Endovascular Management of Chronic Type B Aortic Dissection

Anatoly Loskutov, Monica Cooley, Matthew Scheidt, Neel Mansukhani, Joseph Hart, Robert A. Hieb, Peter J. Rossi, Parag J. Patel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Acute uncomplicated type B aortic dissection (aTBAD) is often treated non operatively, with medical management primarily focused on blood pressure and heart rate control. After a 3 month period following the initial diagnosis, the dissection is considered chronic. Frequent clinical and imaging follow-up is performed to evaluate for dissection stability, aneurysmal degeneration, and visceral malperfusion, which would represent indication for surgical or endovascular repair. In this article we discuss four cases of chronic type B aortic dissection (cTBAD) managed with thoracic endovascular aortic repair (TEVAR) and varying techniques.

Original languageEnglish (US)
Article number100752
JournalTechniques in Vascular and Interventional Radiology
Volume24
Issue number2
DOIs
StatePublished - Jun 2021

Funding

Disclosures:PJR: Silk Road Medical – Scientific Advisory Board and consultant; Terumo Aortic – Scientific Advisory Board and consultant, research funding, speaker bureau; Endospan – Data Safety Monitoring Board; Gore Medical – research funding. RAV: Medtronic – Medical Advisory Board; Siemens—Research support. PJP: Medtronic- Medical Advisory Board; Boston Scientific - Medical Advisory Board, speaker; Penumbra - consultant, speaker; Cordis – Medical Advisory Board. All other authors have no relevant disclosures.

Keywords

  • TEVAR
  • chronic type B aortic dissection
  • endovascular interventions
  • false lumen

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Endovascular Management of Chronic Type B Aortic Dissection'. Together they form a unique fingerprint.

Cite this